Latest market price
8.29
+0.34+4.28%
OverviewShort InterestFilings
IBRXQT63ImmunityBio, Inc.·NASDAQ
8.29+4.28%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 14, 20268-KCurrent report
Oct 06, 20264Statement of changes in beneficial ownership
Oct 06, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 18, 20268-KCurrent report
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 30, 2026ARSAnnual report to shareholders
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 252
Page
▼
/ 11